STERIS plc (Ireland) Ordinary Shares (STE) Covered Calls
STERIS plc (STE) is a leading global provider of infection prevention and procedural products and services. Headquartered in Mentor, Ohio, the company supports healthcare providers, pharmaceutical manufacturers, and medical device companies worldwide. STERIS delivers a comprehensive portfolio, including sterilization equipment, surgical tables, connectivity solutions, and specialized contract sterilization services, all critical to maintaining safe, sterile clinical and scientific environments.
You can sell covered calls on STERIS plc (Ireland) Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for STE (prices last updated Fri 4:16 PM ET):
| STERIS plc (Ireland) Ordinary Shares (STE) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 214.57 | +2.22 | 207.49 | 226.23 | 1.4M | 30 | 21 |
| Covered Calls For STERIS plc (Ireland) Ordinary Shares (STE) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 210 | 5.70 | 220.53 | -4.8% | -219.0% | |
| Apr 17 | 210 | 8.60 | 217.63 | -3.5% | -35.5% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
STERIS plc operates through three core reporting segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment provides capital equipment (such as sterilizers and washer-disinfectors), instrument management systems, and consumables for sterile processing departments and operating rooms. The AST segment leverages a global network of facilities to provide contract sterilization and laboratory services for medical device and pharmaceutical clients. The Life Sciences segment offers specialized equipment, chemical formulations, and services designed to support biopharmaceutical manufacturing and laboratory research environments.
A primary differentiator for STERIS is its role as an "essential utility" for the medical and life science industries. Because its products and services are critical to patient safety and regulatory compliance, the firm benefits from high barriers to entry and predictable, recurring revenue streams. STERIS is currently prioritizing the expansion of its AST capacity to meet rising demand from global MedTech innovators and is integrating advanced digital connectivity into its capital equipment to enable remote monitoring and predictive maintenance, further deepening its role within customer workflows.
Competitive Landscape
STERIS operates in the highly specialized and regulated medical technology market. Key optionable competitors include:
- GE HealthCare Technologies (GEHC): A massive global player in medical imaging and clinical solutions. While GEHC is more heavily weighted toward diagnostic equipment, it competes for hospital capital expenditure budgets, forcing STERIS to maintain its unique focus on infection prevention and sterilization as a distinct value proposition.
- Zimmer Biomet (ZBH): A leader in musculoskeletal healthcare. As a major consumer of sterile implants and related surgical equipment, Zimmer Biomet operates in the same ecosystem; while not a direct product competitor in sterilization, it influences the procedure volumes that drive demand for STERIS’s healthcare offerings.
- ResMed (RMD): A leader in respiratory care and connected health solutions. ResMed serves as a peer in the high-margin medical technology sector, with investors often comparing STERIS’s clinical reliability and recurring service revenue against ResMed’s focus on chronic disease management and device-based diagnostics.
Strategic Outlook and Innovation
STERIS is executing a strategy centered on sustained growth in its Healthcare and AST segments. Management is actively optimizing its manufacturing footprint and investing in high-growth bioprocessing and pharmaceutical support services. The firm is also focused on deleveraging its balance sheet following past strategic acquisitions, supported by strong, consistent free cash flow generation.
Looking ahead, STERIS aims to leverage its dominant market position to capture share in both mature and emerging healthcare markets. By focusing on mission-critical infection control and expanding its digital service capabilities, the company intends to remain an indispensable partner, navigating evolving global safety standards while delivering consistent, reliable shareholder value.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PL covered calls | |
| 3. | SPY covered calls | 8. | IWM covered calls | 3. | RCAT covered calls | |
| 4. | EEM covered calls | 9. | FXI covered calls | 4. | AXTI covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | LUNR covered calls | |
Want more examples? STC Covered Calls | STEM Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
